Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-28

FDA Approved: SUNOSI — Supplemental Application (Axsome Therapeutics, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Sunosi (solriamfetol) from Axsome Therapeutics, Inc., pertaining to updates to the drug's labeling or indication…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sunosi (solriamfetol)

Snippet

SUPPL AP for SUNOSI (SOLRIAMFETOL)